Regulations Governing Accreditation and Management of Drug Abuse Urine Testing and Medical Institutions Article 14
In case of alteration of name, address, principal, responsible person, certifying scientist, initial test method, confirmatory test method or testing instrument, the testing institution shall, within thirty days after alteration, submit the related data to the executive institution for approval, and the executive institution shall carry out inspection if necessary.When the alteration of address in the preceding paragraph is related to the relocation of testing instruments, the report of the relocating testing instruments, schedule, address and a geographical location map shall be submitted to the executive institution for approval. The executive institution shall announce the relocating schedule on the website.After the alteration is complete in the preceding paragraph, the test can be proceeded after the receiving the approval from the executive institution.
中文原文 濫用藥物尿液檢驗及醫療機構認可管理辦法第14條
檢驗機構之機構名稱、地址、負責人、檢驗負責人、專責品管人員、初步檢驗方法、確認檢驗方法或檢驗儀器之變更,應檢具相關文件、資料,於變更後三十日內報執行機關核定;必要時,執行機關得進行實地評鑑。
前項地址變更,涉及檢驗儀器放置地點之異動者,應先向執行機關提報搬遷之檢驗儀器、時程、地址及地理位置簡圖;執行機關應將搬遷時程於網站公告之。
前項變更完成後,應經執行機關核定,始得進行檢驗。
前項地址變更,涉及檢驗儀器放置地點之異動者,應先向執行機關提報搬遷之檢驗儀器、時程、地址及地理位置簡圖;執行機關應將搬遷時程於網站公告之。
前項變更完成後,應經執行機關核定,始得進行檢驗。